Insider trade

Hims & Hers Health (HIMS)Director sold ~$799K

Patrick Harrison Carroll, Director at Hims & Hers Health, sold ~$799K of Hims & Hers Health shares.

~$799K
Approx. value · 23K sh @ $34.31
210K
Holds after · shares reported
Traded
Mar 18, 2025
Filed
Mar 18, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 16, 2025Insider · 1 personInsiders: 6 sales (~$2.3M)
  2. Jan 21, 2025Insider · 4 peopleInsiders: 10 sales (~$3.6M)
  3. Jan 22, 2025InsiderCEO sold ~$429K of HIMS shares in the open market
  4. Jan 23, 2025InsiderCEO sold ~$815K of HIMS shares in the open market
  5. Jan 24, 2025InsiderOfficer sold ~$536K of HIMS shares in the open market
  6. Jan 31, 2025InsiderCEO sold ~$3.52M of HIMS shares in the open market
  7. Feb 3, 2025Insider · 2 peopleInsiders: 2 sales (~$219K)
  8. Feb 4, 2025Insider · 1 personInsiders: 4 sales (~$451K)
  9. Feb 10, 2025Insider · 2 peopleInsiders: 4 sales (~$812K)
  10. Feb 12, 2025Insider · 1 personInsiders: 4 sales (~$3.0M)
  11. Feb 18, 2025Insider · 2 peopleInsiders: 9 sales (~$10.5M)
  12. Feb 19, 2025InsiderOfficer sold ~$444K of HIMS shares in the open market
  13. Feb 24, 2025InsiderOfficer sold ~$833K of HIMS shares in the open market
  14. Mar 3, 2025Insider · 2 peopleInsiders: 2 sales (~$319K)
  15. Mar 5, 2025InsiderDirector sold ~$500K of HIMS shares in the open market
  16. Mar 11, 2025InsiderOfficer sold ~$77K of HIMS shares in the open market
  17. Mar 17, 2025Insider · 1 personInsiders: 8 sales (~$6.0M)
  18. Mar 18, 2025 · this disclosureInsiderDirector sold ~$799K of HIMS shares in the open market

What came next

  1. Mar 18, 2025Insider · 3 peopleInsiders: 4 sales (~$3.1M)
  2. Mar 21, 2025InsiderCFO sold ~$749K of HIMS shares in the open market
  3. Mar 26, 2025Insider · 1 personInsiders: 5 sales (~$2.4M)
  4. Mar 31, 2025InsiderOfficer sold ~$90K of HIMS shares in the open market
  5. Apr 2, 2025InsiderCFO sold ~$339K of HIMS shares in the open market
  6. Apr 3, 2025InsiderOfficer sold ~$63K of HIMS shares in the open market
  7. Apr 9, 2025Insider · 1 personInsiders: 4 sales (~$911K)
  8. Apr 14, 2025InsiderOfficer sold ~$93K of HIMS shares in the open market
  9. Apr 15, 2025InsiderCFO sold ~$330K of HIMS shares in the open market
  10. Apr 16, 2025Insider · 1 personInsiders: 3 sales (~$2.4M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Hims & Hers Health

For Hims & Hers Health, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 4 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HIMS page.

Other recent filings by Patrick Harrison Carroll, Chief Medical Officer

The full history of Patrick Harrison Carroll, Chief Medical Officer is on the profile page.

How this filing works

Other disclosures at Hims & Hers Health

Everything OQRO holds on this company is on its HIMS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data